|
MetroGel® 1% is
manufactured by Galderma Laboratories in
Canada and is FDA approved for use as a
topical treatment for rosacea. Its
primary active ingredient
is metronidazole and is classified
as an anti-bacterial
agent. This is a
powerful topical gel and must be used
only according to your doctor's
recommendations.
Clinical lab testing
showed that this rosacea treatment
experienced a 71% reduction in
inflammatory bumps and pimples after
a treatment period of ten weeks.
MetroGel is designed for application only
once per day and is recommended for use
as part of a daily skin care program.
Because this rosacea product only
addresses lesions, it should be
combined with a cleanser for sensitive
skin, a quality skin moisturizer and
an effective sun blocking
agent.
Because of the strength of
the MetroGel's primary ingredient,
metronidazole, adverse reactions in some
individuals has
been noted.
These adverse reactions include:
burning, skin irritation, dryness,
transient redness, metallic taste,
tingling or numbness of extremities and
nausea. However, in clinical trial
these side effects were generally
transient in nature and occur primarily
in the early stages of the rosacea
treatment.
The MetroGel® 1% gel consists
of metronidazole in a base of betadex,
edetate disodium, hydroxyethyl cellulose,
methylparaben, niacinamide, phenoxyethanol,
propylene glycol, propylparaben and purified
water.
Features:
>>Visit the
MetroGel
Site<<
|